[ALA] QoQ Quarter Result on 30-Jun-2019 [#Q4]

Stock
[ALA] Arovella Therapeutics Limited
Announcement Date
29-Jun-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q4]
Profit Trend
QoQ- -100.03%
YoY- -263.90%
Quarter Report
ALA's Result
ALA's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Revenue 106 370 192 396 198 427 427 -60.46%
PBT -1,446 -7,699 -3,850 -7,850 -3,925 -435 -435 122.57%
Tax -328 0 0 -925 463 0 0 -
NP -1,118 -7,699 -3,850 -6,925 -3,462 -435 -435 87.52%
Tax Rate - - - - - - - -
Total Cost 1,224 8,069 4,041 7,321 3,660 862 862 26.30%
Ratio Analysis
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
NP Margin -1,053.37 -2,081.94 -2,008.97 -1,748.22 -1,748.22 -101.83 -101.83 374.08%
Per Share
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
EPS -0.01 -0.05 -0.03 -0.04 -0.03 -0.00 -0.00 -
EPS Diluted -0.01 -0.05 -0.03 -0.04 -0.03 -0.00 -0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.